1.Multidisciplinary team-based real-world study of patients with hepatitis B-related liver cancer
Huimin LIU ; Shilian LI ; Lijian RAN ; Jing WANG ; Wenting CHEN ; Baoyan XU ; Wenting TAN ; Jie XIA ; Qing MAO
Chinese Journal of Experimental and Clinical Virology 2025;39(4):403-410
Objective:To investigate the clinical characteristics of patients with hepatitis B virus(HBV)-related primary hepatocellular carcinoma(HCC)who were treated in a multidisciplinary team(MDT)for liver cancer,so as to provide a basis for clinical optimization of the diagnosis and treatment of patients with chronic hepatitis B(CHB).Methods:A retrospective analysis was performed for 482 HBV-related HCC patients who were treated with HCC-MDT every Thursday afternoon in The First Affiliated Hospital of the Army Medical University from January 2022 to May 2024,aged 18-87(55.54±10.84)years,86.93%(419/482)males and 13.07%(63/482)females. According to the different underlying liver diseases at the time of initial medical treatment and the different prognostic outcomes at the later follow-up,the differences in clinical characteristics between groups under different conditions were compared and analyzed,and the influencing factors of HCC prognosis were understood by Logistic regression analysis. Results:At the time of MDT presentation,the differences in HBeAg status( χ2=6.311 ,P=0.043),γ-glutamyl traspeptidase(GGT)( Z=6.277, P=0.043),alkaline phosphatase(ALP)( Z=7.236 ,P=0.027),and model for end-stage liver disease(MELD)scores( Z=6.111, P=0.047)among patients with different underlying liver diseases were statistically significant. At follow-up,6.75%(11/163)of HBV-related HCC patients who presented to MDT had a family history of HCC,and their cumulative mortality rate was as high as 60.8%(205/337)at least for 1 year. Mulitivariate Logistic regression analysis showed that different underlying liver disease at the time of initial medical treatment,HBV DNA replication level,MELD score and choice of anti-cancer treatment regimen were the influencing factors for the prognosis of HCC(all P<0.05). The worse the degree of cirrhosis at the initial presentation,the higher the level of HBV DNA replication,and the higher the MELD score,the worse the prognosis for HCC. Conclusion:Advancing the diagnosis and treatment of CHB,maximizing the inhibition of HBV DNA replication,reducing the MELD score,and optimizing the anti-cancer treatment regimen can reduce the mortality rate of HBV-related HCC.
2.Efficacy of nucleos(t)ide analogues combined with peginterferon α-2b on antiviral therapy in children with chronic hepatitis B
Wenting CHEN ; Shilian LI ; Xiaochen MA ; Fang CHEN ; Lijian RAN ; Yi WU ; Yan GUO ; Yan ZHU ; Qing MAO ; Huimin LIU
Chinese Journal of Experimental and Clinical Virology 2025;39(4):411-418
Objective:To analyze the efficacy of combination of peginterferon α-2b(Peg-IFN α-2b)with nucleos(t)ide analogues(NAs)on antiviral therapy in children with chronic hepatitis B(CHB)and to provide an optimized clinical treatment strategies for CHB children.Methods:A retrospective analysis was conducted on 30 CHB children treated in The First Affiliated Hospital of the Army Medical University(Southwest Hospital)from January 2022 to January 2025 with treatment duration at least 48 weeks. The enrolled children were aged between 2 and 17 years and divided into the NAs combined with Peg-IFN α-2b(NPI)group(n=13)and NAs group(n=17)by their therapy regimens. The characteristics of baseline,week 12,week 24,week 48 and week 96 were compared between groups,as well as the differences in response to biochemical,immune and viral indicators at each observation point. Logistic regression analysis and receiver operating characteristic(ROC)curve analysis were performed to identify factors influencing the HBsAg seroclearance. Results:At baseline of treatment,the proportion of HBeAg positivity in the NPI group and the NAs group was high(76.9% vs 86.6%, χ2=0.679, P=0.628),and the alanine aminotransferase(ALT)and aspartate aminotransferase(AST)in the NPI group were significantly lower than those in the NAs group( P<0.001). At 24 weeks,the decrease in HBsAg in the NPI group was also significantly higher than that in the NAs group( Z=-3.161, P=0.002). Finally,the cumulative seroclearance rate of HBsAg at 96 weeks in the NPI group was significantly higher than that in the NAs group(46.15% vs 5.88%, χ2=0.679, P=0.025). Mulitivariate Logistic regression analysis showed that treatment regimen and gender were risk factors affecting the outcome of HBsAg( P<0.05). ROC curve analysis showed that the increase in ALT at 12 weeks compared with baseline(AUC=0.857,Cutoff value=3.615 IU/L),the decrease in ALT at 24 weeks(AUC=0.870,Cutoff value=47.85 IU/L),and the decrease in HBsAg at 12 weeks and especially at 24 weeks(AUC=0.885,Cutoff value=0.97log IU/ml)were effective predictors of HBsAg prognosis at 96 weeks. Conclusion:In CHB children,antiviral regimen Peg-IFN α-2b combined with NAs was more effective than NAs alone in improving the HBsAg seroclearance rate of CHB,and the effects in female were better than in male. The decline of HBsAg and the fluctuation of ALT in the early treatment period are valid predictors of HBsAg clearance.
3.Three-dimensional finite element analysis of anterior femoral notching during total knee arthroplasty at different bone strengths
Jinhai ZHOU ; Jiangwei LI ; Xuquan WANG ; Ying ZHUANG ; Ying ZHAO ; Yuyong YANG ; Jiajia WANG ; Yang YANG ; Shilian ZHOU
Chinese Journal of Tissue Engineering Research 2025;29(9):1775-1782
BACKGROUND:Periprosthetic fracture of the femoral of the knee after total knee arthroplasty is one of the common complications,and there is a lack of biomechanical research on the periprosthetic fractures of the femoral of the knee under different bone strength conditions.The three-dimensional finite element analysis can provide a biomechanical basis for clinical practice. OBJECTIVE:To investigate the biomechanical changes of anterior femoral notching after total knee arthroplasty under different bone strengths,and to provide a mechanical basis for the clinical prevention of supracondylar femoral periprosthetic fractures after knee arthroplasty. METHODS:The femoral CT data of healthy adults were obtained,and the three-dimensional model of femoral lateral replacement of the knee joint was established by Mimics,Geomagic studio,and Solidworks software.Anterior femoral notching models of different depths were constructed,and the models were imported into ANSYS software to analyze the changes of biological stress on the femoral condyle with different bone strengths and different anterior femoral notching depths.The stress changes of the femoral anterior condyle section after and before the filling of anterior femoral notching with bone cement were analyzed. RESULTS AND CONCLUSION:(1)Under any bone strength,the supracondylar stress increased with the depth of anterior femoral notching.In normal bone conditions,there was a stress abrupt change point when the anterior femoral notching depth was between 3 mm and 4 mm.In the case of osteoporosis,there was a stress abrupt point when the anterior femoral notching depth was between 2 mm and 3 mm.(2)When anterior femoral notching occurred during knee arthroplasty and the depth exceeded the thickness of the bone cortex,the supracondylar stress of the femoral gradually increased as the bone strength decreased.(3)The stress of the anterior femoral condyle section decreased when the model with an anterior femoral notching depth of 3 mm was filled with bone cement.(4)The results show that anterior femoral notching should be avoided during knee arthroplasty,especially in patients with osteoporosis.If anterior femoral notching occurs during surgery,bone cement can be used to evenly fill the anterior femoral notching to reduce the supracondylar stress of the femur and reduce the incidence of periprosthetic fractures of the femoral joint
4.Multidisciplinary team-based real-world study of patients with hepatitis B-related liver cancer
Huimin LIU ; Shilian LI ; Lijian RAN ; Jing WANG ; Wenting CHEN ; Baoyan XU ; Wenting TAN ; Jie XIA ; Qing MAO
Chinese Journal of Experimental and Clinical Virology 2025;39(4):403-410
Objective:To investigate the clinical characteristics of patients with hepatitis B virus(HBV)-related primary hepatocellular carcinoma(HCC)who were treated in a multidisciplinary team(MDT)for liver cancer,so as to provide a basis for clinical optimization of the diagnosis and treatment of patients with chronic hepatitis B(CHB).Methods:A retrospective analysis was performed for 482 HBV-related HCC patients who were treated with HCC-MDT every Thursday afternoon in The First Affiliated Hospital of the Army Medical University from January 2022 to May 2024,aged 18-87(55.54±10.84)years,86.93%(419/482)males and 13.07%(63/482)females. According to the different underlying liver diseases at the time of initial medical treatment and the different prognostic outcomes at the later follow-up,the differences in clinical characteristics between groups under different conditions were compared and analyzed,and the influencing factors of HCC prognosis were understood by Logistic regression analysis. Results:At the time of MDT presentation,the differences in HBeAg status( χ2=6.311 ,P=0.043),γ-glutamyl traspeptidase(GGT)( Z=6.277, P=0.043),alkaline phosphatase(ALP)( Z=7.236 ,P=0.027),and model for end-stage liver disease(MELD)scores( Z=6.111, P=0.047)among patients with different underlying liver diseases were statistically significant. At follow-up,6.75%(11/163)of HBV-related HCC patients who presented to MDT had a family history of HCC,and their cumulative mortality rate was as high as 60.8%(205/337)at least for 1 year. Mulitivariate Logistic regression analysis showed that different underlying liver disease at the time of initial medical treatment,HBV DNA replication level,MELD score and choice of anti-cancer treatment regimen were the influencing factors for the prognosis of HCC(all P<0.05). The worse the degree of cirrhosis at the initial presentation,the higher the level of HBV DNA replication,and the higher the MELD score,the worse the prognosis for HCC. Conclusion:Advancing the diagnosis and treatment of CHB,maximizing the inhibition of HBV DNA replication,reducing the MELD score,and optimizing the anti-cancer treatment regimen can reduce the mortality rate of HBV-related HCC.
5.Efficacy of nucleos(t)ide analogues combined with peginterferon α-2b on antiviral therapy in children with chronic hepatitis B
Wenting CHEN ; Shilian LI ; Xiaochen MA ; Fang CHEN ; Lijian RAN ; Yi WU ; Yan GUO ; Yan ZHU ; Qing MAO ; Huimin LIU
Chinese Journal of Experimental and Clinical Virology 2025;39(4):411-418
Objective:To analyze the efficacy of combination of peginterferon α-2b(Peg-IFN α-2b)with nucleos(t)ide analogues(NAs)on antiviral therapy in children with chronic hepatitis B(CHB)and to provide an optimized clinical treatment strategies for CHB children.Methods:A retrospective analysis was conducted on 30 CHB children treated in The First Affiliated Hospital of the Army Medical University(Southwest Hospital)from January 2022 to January 2025 with treatment duration at least 48 weeks. The enrolled children were aged between 2 and 17 years and divided into the NAs combined with Peg-IFN α-2b(NPI)group(n=13)and NAs group(n=17)by their therapy regimens. The characteristics of baseline,week 12,week 24,week 48 and week 96 were compared between groups,as well as the differences in response to biochemical,immune and viral indicators at each observation point. Logistic regression analysis and receiver operating characteristic(ROC)curve analysis were performed to identify factors influencing the HBsAg seroclearance. Results:At baseline of treatment,the proportion of HBeAg positivity in the NPI group and the NAs group was high(76.9% vs 86.6%, χ2=0.679, P=0.628),and the alanine aminotransferase(ALT)and aspartate aminotransferase(AST)in the NPI group were significantly lower than those in the NAs group( P<0.001). At 24 weeks,the decrease in HBsAg in the NPI group was also significantly higher than that in the NAs group( Z=-3.161, P=0.002). Finally,the cumulative seroclearance rate of HBsAg at 96 weeks in the NPI group was significantly higher than that in the NAs group(46.15% vs 5.88%, χ2=0.679, P=0.025). Mulitivariate Logistic regression analysis showed that treatment regimen and gender were risk factors affecting the outcome of HBsAg( P<0.05). ROC curve analysis showed that the increase in ALT at 12 weeks compared with baseline(AUC=0.857,Cutoff value=3.615 IU/L),the decrease in ALT at 24 weeks(AUC=0.870,Cutoff value=47.85 IU/L),and the decrease in HBsAg at 12 weeks and especially at 24 weeks(AUC=0.885,Cutoff value=0.97log IU/ml)were effective predictors of HBsAg prognosis at 96 weeks. Conclusion:In CHB children,antiviral regimen Peg-IFN α-2b combined with NAs was more effective than NAs alone in improving the HBsAg seroclearance rate of CHB,and the effects in female were better than in male. The decline of HBsAg and the fluctuation of ALT in the early treatment period are valid predictors of HBsAg clearance.
6.Visual analysis of research progress and hot topics in diet of prediabetic population
Shilian NIU ; Li YUAN ; Rao LI
Journal of Clinical Medicine in Practice 2024;28(15):134-141
Objective To understand the hot topics and development trends of research on diet-related issues in prediabetes population through bibliometric methods, providing ideas and references for future research directions in this field. Methods The relevant literature on diet in the prediabetes population published in the Social Science Citation Index (SSCI) database from January 1990 to September 2023 in the Web of Science database was retrieved. The data of publication volume, countries/regions, institutions, authors, journals, and keywords were statistically and visually analyzed using CiteSpace software. Results A total of 2, 083 articles were retrieved and included in the final analysis. The country with the highest number of publications was the United States (718 articles), the institution with the highest number of publications was Harvard University (209 articles), and the author with the highest number of publications was TUOMILEHTO J from the University of Helsinki (35 articles). High-frequency keywords in the research included impaired glucose tolerance, insulin resistance, risk, diabetes, and obesity. Emerging keywords included individuals, Mediterranean diet, meta-analysis, overweight, adults, management, and impact. A total of 16 clusters were obtained through keyword clustering, including research on mechanisms, influencing factors and risk analysis, and dietary interventions. Conclusion The research hotspots on diet in the prediabetes population focus on the related mechanisms of adipose tissue, gut microbiota, changes in Mediterranean diet research, and dietary interventions for prediabetes. Future research should continue to explore the physiological mechanisms related to diet in the prediabetes population, providing a basis for the ultimate precise and personalized dietary intervention mode and verification for prediabetes, and reducing the incidence of diabetes.
7.Epidemiological characteristics and spatiotemporal clustering analysis of Japanese encephalitis in Yunnan province from 2000 to 2023
Shuzhen DENG ; Cong HUA ; Shilian WANG ; Wenwen LI ; Hailin ZHANG
Chinese Journal of Experimental and Clinical Virology 2024;38(6):642-648
Objective:To analyze the epidemiological characteristics of Japanese encephalitis (JE) in Yunnan province, China from 2000 to 2023, and to provide scientific basis for prevention and control work.Methods:Descriptive epidemiological method were used for epidemiological feature analysis. Excel 2019 and ArcGIS 10.8.2 software were used to establish case databases and map drawings, Joinpoint 4.9.1 software was used to conduct time trend analysis, and ArcGIS 10.8.2 software was used to construct a geographic information database and conduct spatial autocorrelation analysis. SaTScan 10.1.2 software was used for spatiotemporal scanning analysis.Results:A total of 7 006 JE cases and 342 deaths were reported in Yunnan province from 2000 to 2023, with an average annual incidence of 0.58/100 000 (0.03/100 000-1.69/100 000) and a fatality rate of 4.88%, both of which showed a decreasing trend. JE cases have been reported in 129 counties in 16 prefectures of the province, and the average annual incidence rate in prefecture was 0.09/100 000-1.96/100 000. Xishuangbanna, Dehong, Zhaotong, Baoshan, Pu′er, Wenshan and Chuxiong prefectures were highly prevalent areas. Spatial-temporal scanning analysis found that 33 counties in 6 prefectures in the China-Myanmar and China-Laos border areas in southwest Yunnan constitute the first-class cluster area, and 9 counties in Zhaotong prefecture in northeastern Yunnan constitute the second-class cluster area. JE cases occured in every month of the year, with the main epidemic period from May to October. The ratio of male to female cases was 1.54∶1, the proportion of the age group <15 years was 68.49%, and the age group ≥15 years was 31.51%. The proportion of scattered children and preschool children was 38.54%, with students accounting for 33.19% and farmers accounting for 21.18%.Conclusions:JE was widely distributed in Yunnan province, with high-incidence areas mainly concentrated in southwestern and northeastern Yunnan. The incidence rate among children was high, and the number of cases among adults and farmers has increased significantly. It is still necessary to strengthen the prevention and control of JE in high-risk areas, especially in rural areas, and fully implement the children′s JE immunization program and adult JE prevention measures.
8.Epidemiological characteristics and spatiotemporal clustering analysis of Japanese encephalitis in Yunnan province from 2000 to 2023
Shuzhen DENG ; Cong HUA ; Shilian WANG ; Wenwen LI ; Hailin ZHANG
Chinese Journal of Experimental and Clinical Virology 2024;38(6):642-648
Objective:To analyze the epidemiological characteristics of Japanese encephalitis (JE) in Yunnan province, China from 2000 to 2023, and to provide scientific basis for prevention and control work.Methods:Descriptive epidemiological method were used for epidemiological feature analysis. Excel 2019 and ArcGIS 10.8.2 software were used to establish case databases and map drawings, Joinpoint 4.9.1 software was used to conduct time trend analysis, and ArcGIS 10.8.2 software was used to construct a geographic information database and conduct spatial autocorrelation analysis. SaTScan 10.1.2 software was used for spatiotemporal scanning analysis.Results:A total of 7 006 JE cases and 342 deaths were reported in Yunnan province from 2000 to 2023, with an average annual incidence of 0.58/100 000 (0.03/100 000-1.69/100 000) and a fatality rate of 4.88%, both of which showed a decreasing trend. JE cases have been reported in 129 counties in 16 prefectures of the province, and the average annual incidence rate in prefecture was 0.09/100 000-1.96/100 000. Xishuangbanna, Dehong, Zhaotong, Baoshan, Pu′er, Wenshan and Chuxiong prefectures were highly prevalent areas. Spatial-temporal scanning analysis found that 33 counties in 6 prefectures in the China-Myanmar and China-Laos border areas in southwest Yunnan constitute the first-class cluster area, and 9 counties in Zhaotong prefecture in northeastern Yunnan constitute the second-class cluster area. JE cases occured in every month of the year, with the main epidemic period from May to October. The ratio of male to female cases was 1.54∶1, the proportion of the age group <15 years was 68.49%, and the age group ≥15 years was 31.51%. The proportion of scattered children and preschool children was 38.54%, with students accounting for 33.19% and farmers accounting for 21.18%.Conclusions:JE was widely distributed in Yunnan province, with high-incidence areas mainly concentrated in southwestern and northeastern Yunnan. The incidence rate among children was high, and the number of cases among adults and farmers has increased significantly. It is still necessary to strengthen the prevention and control of JE in high-risk areas, especially in rural areas, and fully implement the children′s JE immunization program and adult JE prevention measures.
9.Key points of EASL Clinical Practice Guidelines on hepatitis delta virus (2023)
Huimin LIU ; Wenting CHEN ; Shilian LI ; Hongmei GONG ; Qing. MAO
Journal of Clinical Hepatology 2023;39(11):2558-2563
Due to significant innovations in the diagnosis and treatment of hepatitis D virus (HDV), the European Society of Hepatology (EASL) published its first international clinical practice guidelines on the management of individuals with HDV infection in July 2023. The guidelines mainly focus on the six aspects of HDV screening, diagnosis, clinical features and influencing factors, patient monitoring and selection for treatment, therapeutic methods and treatment endpoints. The guidelines give recommendations by answering and elaborating on 13 questions covering these six aspects. In addition, the guidelines also provide the prospect of the future treatment of HDV. The author’s team makes an excerpt of the guidelines and systematically introduces various evaluation points in recommendations and clinical management suggestions, in order to promote the development of clinical management and decision-making for individuals with HDV infection in China.
10.Efficacy and safety of fecal microbiota transplantation for the treatment of chronic functional constipation in the elderly
Xiping DING ; Xiang FANG ; Shi YIN ; Zhongliang FANG ; Bilin HUANG ; Ye LI ; Weigang ZHAO ; Geng BIAN ; Baolin SUN ; Shilian HU
Chinese Journal of Geriatrics 2022;41(8):941-945
Objective:To evaluate the clinical efficacy and safety of fecal microbiota transplantation(FMT)for the treatment of chronic functional constipation in the elderly.Methods:A total of 33 elderly patients with chronic functional constipation were included and given three sessions of FMT.Changes in fecal characteristics, constipation, mood and quality of life in these patients were evaluated using the Bristol stool form scale(BSFS), the constipation assessment scale(CAS), patient assessment of constipation symptoms(PAC-SYM), the Zung self-rating anxiety scale(SAS), the Zung self-rating depression scale(SDS), and the patient assessment of constipation quality of life(PAC-QOL)before and 12 weeks after treatment.The clinical efficacy was based on comparison between pre-and post-treatment results for each patient.Results:Clear improvement was achieved in 33 patients 12 weeks after treatment, compared with before transplantation.Post-treatment scores of the constipation assessment scale and symptom self-assessment questionnaire for patients with constipation were(8.9±1.2)scores and(26.5±2.4)scores, respectively, significantly lower than pre-transplantation scores of(12.2±1.1)scores and(32.4±2.4)scores( t=15.034, 13.904, both P<0.001). Similarly, post-treatment scores were also lower than pre-transplantation levels for the self-rating anxiety scale[(50.4±8.4)scores vs.(57.5±9.0)scores, t=10.333, P<0.001], the self-rating depression scale[(50.6±8.4)% vs.(55.0±10.5)%, t=5.301, P<0.001], and self-assessment questionnaire for quality of life[(88.2±7.3)scores vs.(103.7±7.3)scores, t=23.300, P<0.001]. Conclusions:FMT can improve fecal characteristics and constipation symptoms, relieve anxiety and depression, improve the quality of life, and provide a new option for the treatment for elderly patients with chronic functional constipation.


Result Analysis
Print
Save
E-mail